Passage Bio, Inc.

PASGNASDAQHealthcare● Active

$5.47

$-0.15(-2.67%)

Market Cap$17546721

P/E Ratio—

52W High$20

52W Low$3.935

Avg Volume79K

Open$5.69

Beta1.41

Overview

Passage Bio, Inc.（PASG）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · PASG · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.55

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 35%仅显示有效交易 · 排除RSU归属65% Sell ↓

Passage Bio, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

PASG 季度内部人买卖趋势

PASG 内幕交易卖出 · PASG 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.4M687K0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · PASG CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

PASG 高管卖出股份 · PASG 董事内幕交易 · SEC Form 4申报

显示最近 49 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jan 8, 2026	Chou William PRESIDENT AND CEO · Director	Option	10,000	—	—	10,600	Form 4
Jan 8, 2026	Chou William PRESIDENT AND CEO · Director	Sale	4,076	$18.44	$75K	6,524	Form 4
Jan 8, 2026	Borthwick Kathleen CFO	Option	5,000	—	—	7,464	Form 4
Jan 8, 2026	Borthwick Kathleen CFO	Sale	2,062	$18.44	$38K	5,402	Form 4
Sep 15, 2025	Lynx1 Capital Management LP 10 percent owner	Purchase	11,900	$6.99	$83K	623,704	Form 4
Sep 12, 2025	Lynx1 Capital Management LP 10 percent owner	Purchase	19,783	$6.99	$138K	611,804	Form 4
Jul 24, 2025	Lynx1 Capital Management LP 10 percent owner	Purchase	66,423	$5.71	$379K	591,696	Form 4
Jul 23, 2025	Lynx1 Capital Management LP 10 percent owner	Purchase	49,302	$5.74	$283K	525,273	Form 4
Jun 24, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	231,600	$0.35	$81K	6,418,400	Form 4
Jun 25, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	138,800	$0.33	$46K	6,279,600	Form 4
Jun 26, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	213,257	$0.33	$70K	6,066,343	Form 4
Apr 22, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	78,049	$0.34	$27K	6,807,523	Form 4
Apr 23, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	89,328	$0.34	$30K	6,718,195	Form 4
Apr 24, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	68,195	$0.32	$22K	6,650,000	Form 4
Apr 15, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	10,326	$0.38	$4K	7,024,300	Form 4
Apr 16, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	61,638	$0.33	$20K	6,962,662	Form 4
Apr 17, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	77,090	$0.33	$25K	6,885,572	Form 4
Feb 10, 2025	Borthwick Kathleen CFO	Option	8,000	—	—	44,466	Form 4
Feb 11, 2025	Borthwick Kathleen CFO	Sale	3,183	$0.53	$2K	41,283	Form 4
Jan 10, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	126,209	$0.66	$83K	7,131,636	Form 4
Jan 13, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	17,986	$0.64	$12K	7,113,650	Form 4
Jan 14, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	79,024	$0.60	$47K	7,034,626	Form 4
Jan 6, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	19,481	$0.77	$15K	7,385,388	Form 4
Jan 7, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	52,536	$0.71	$37K	7,332,852	Form 4
Jan 8, 2025	ORBIMED ADVISORS LLC 10 percent owner	Sale	75,007	$0.68	$51K	7,257,845	Form 4

Chou William

PRESIDENT AND CEO · Director

Option

日期

Jan 8

股数

10,000

均价

—

总金额

—

View Form 4 on SEC.gov

Chou William

PRESIDENT AND CEO · Director

Sale

日期

Jan 8

股数

4,076

均价

$18.44

总金额

$75K

View Form 4 on SEC.gov

Borthwick Kathleen

CFO

Option

日期

Jan 8

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Borthwick Kathleen

CFO

Sale

日期

Jan 8

股数

2,062

均价

$18.44

总金额

$38K

View Form 4 on SEC.gov

Lynx1 Capital Management LP

10 percent owner

Purchase

日期

Sep 15

股数

11,900

均价

$6.99

总金额

$83K

View Form 4 on SEC.gov

Lynx1 Capital Management LP

10 percent owner

Purchase

日期

Sep 12

股数

19,783

均价

$6.99

总金额

$138K

View Form 4 on SEC.gov

Lynx1 Capital Management LP

10 percent owner

Purchase

日期

Jul 24

股数

66,423

均价

$5.71

总金额

$379K

View Form 4 on SEC.gov

Lynx1 Capital Management LP

10 percent owner

Purchase

日期

Jul 23

股数

49,302

均价

$5.74

总金额

$283K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jun 24

股数

231,600

均价

$0.35

总金额

$81K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jun 25

股数

138,800

均价

$0.33

总金额

$46K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jun 26

股数

213,257

均价

$0.33

总金额

$70K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 22

股数

78,049

均价

$0.34

总金额

$27K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 23

股数

89,328

均价

$0.34

总金额

$30K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 24

股数

68,195

均价

$0.32

总金额

$22K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 15

股数

10,326

均价

$0.38

总金额

$4K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 16

股数

61,638

均价

$0.33

总金额

$20K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Apr 17

股数

77,090

均价

$0.33

总金额

$25K

View Form 4 on SEC.gov

Borthwick Kathleen

CFO

Option

日期

Feb 10

股数

8,000

均价

—

总金额

—

View Form 4 on SEC.gov

Borthwick Kathleen

CFO

Sale

日期

Feb 11

股数

3,183

均价

$0.53

总金额

$2K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 10

股数

126,209

均价

$0.66

总金额

$83K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 13

股数

17,986

均价

$0.64

总金额

$12K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 14

股数

79,024

均价

$0.60

总金额

$47K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 6

股数

19,481

均价

$0.77

总金额

$15K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 7

股数

52,536

均价

$0.71

总金额

$37K

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

10 percent owner

Sale

日期

Jan 8

股数

75,007

均价

$0.68

总金额

$51K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 PASG 内幕交易

PASG 内幕交易

Passage Bio, Inc.（PASG）内幕交易数据来源于公司内部人（包括Lynx1 Capital Management LP (10 percent owner), ORBIMED ADVISORS LLC (10 percent owner), Chou William (PRESIDENT AND CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。PASG内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Passage Bio, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

PASG 内幕交易 · 5个问题

Passage Bio, Inc.（PASG）的内部人包括高管和董事，如Lynx1 Capital Management LP (10 percent owner), ORBIMED ADVISORS LLC (10 percent owner), Chou William (PRESIDENT AND CEO · Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

PASG 董事内幕交易PASG 内部人名单Passage Bio, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026